Loratadine

Manufacturer
Target Corporation | Ranbaxy Pharmaceuticals Inc. | Ohm Laboratories Inc.
Effective date
2012-10-05
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:35:16

Label at a glance#

ProductLoratadine
Active ingredientLORATADINE
Label structure9 sections

Indications and uses

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Dosage and administration

place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Label contents#

Full prescribing information#

ACTIVE INGREDIENT (IN EACH TABLET)

OTC - ACTIVE INGREDIENT SECTION

Loratadine, USP 10 mg

PURPOSE

OTC - PURPOSE SECTION

Antihistamine

USES

INDICATIONS & USAGE SECTION

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

WARNINGS

WARNINGS SECTION

Do not use

OTC - DO NOT USE SECTION

If you have ever had an allergic reaction to this product or any of its ingredients.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

Liver or kidney disease. Your doctor should determine if you need a different dose.

When using this product

OTC - WHEN USING SECTION

Do not take more than directed. Taking more than directed may cause drowsiness.

Stop use and ask a doctor if

OTC - STOP USE SECTION

An allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • place 1 tablet on tongue; tablet disintegrates, with or without water
    adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours
    children under 6 years of age ask a doctor
    consumers with liver or kidney disease ask a doctor

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

  • Phenylketonurics: Contains Phenylalanine 0.6 mg Per Tablet.
  • TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
  • store between 20° to 25° C (68° to 77° F). Protect from excessive moisture.
  • keep in a dry place.
  • use tablet immediately after opening individual blister.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

aspartame, croscarmellose sodium, fruit flavors, magnesium stearate, mannitol, sodium stearyl fumarate

QUESTIONS?

OTC - QUESTIONS SECTION

Call 1-800-910-6874

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 11673-513-12

Original Prescription Strength

non-drowsy**

allergy relief

loratadine orally disintegrating tablets, 10 mg

antihistamine

indoor & outdoor allergies

Compare to active ingredient in Alavert®*

24 HOUR RELIEF

24-hour allergy relief of: sneezing/

runny nose/itchy nose and throat

no water needed/tablets melt in your mouth

for adults and children 6 years and older

mint flavor

**When taken as directed.

See drug facts panel.

up & up™

12 ORALLY DISINTEGRATING TABLETS

Distributed by Target Corporation

5079395/R1210

Alavert - 12's
Alavert - 12's

NDC 11673-527-31

Original Prescription Strength

non-drowsy**

allergy relief

loratadine orally disintegrating tablets,

10 mg antihistamine

indoor & outdoor allergies

Compare to active ingredient in Claritin®Reditabs®*

24-hour allergy relief of: sneezing/runny

nose/itchy, watery eyes/itchy throat or nose

no water needed/tablets melt in your mouth

for adults and children 6 years and older

**When taken as directed.

See drug facts panel.

up & up™

24 HOUR RELIEF

30 ORALLY DISINTEGRATING TABLETS

Distributed by Target Corp.

5079394/R1210

Claritin - 30's
Claritin - 30's

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
311373loratadine 10 MG 24HR Disintegrating Oral TabletPSN3
311373loratadine 10 MG Disintegrating Oral TabletSCD3

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11673-513-692021-01-29C16284748780-19855d018-e840-cd31-e053-dbdaa90ab51aDrug Facts
11673-527-312021-01-29C16284748780-19855d018-e840-cd31-e053-dbdaa90ab51aDrug Facts
11673-527-312019-11-27C16284748780-19855d018-e840-cd31-e053-dbdaa90ab51aDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11673-513-69Loratadine10 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING103
11673-513-69Loratadine1 in 1 CARTONTABLET, ORALLY DISINTEGRATING13
11673-527-31Loratadine30 in 1 BLISTER PACKTABLET, ORALLY DISINTEGRATING303
11673-527-31Loratadine1 in 1 CARTONTABLET, ORALLY DISINTEGRATING13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11673-513LORATADINE TABLET, ORALLY DISINTEGRATING [TARGET CORPORATION]3Legacy NDC, 2 package rows20130424_e2fe073f-14da-424f-a34c-486d666fd649.zip
11673-527LORATADINE TABLET, ORALLY DISINTEGRATING [TARGET CORPORATION]3Legacy NDC, 2 package rows20130424_e2fe073f-14da-424f-a34c-486d666fd649.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
11673-513-12EA - Each11673-513e19c3043-000b-4d16-9272-d4dc3a241fe412013-02-13
11673-527-31EA - Each11673-52733af7c96-b211-4509-8b3f-ad51e18e565512013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LORATADINEACTIVE INGREDIENT7AJO3BO7QN3
LORATADINEACTIVE MOIETY7AJO3BO7QN3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR13
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH483
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I303
MANNITOLINACTIVE INGREDIENT3OWL53L36A3
SODIUM STEARYL FUMARATEINACTIVE INGREDIENT7CV7WJK4UI3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11673-51311673-513-69
11673-52711673-527-31

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 162 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL78 mgExact identifier — unii candidate
19 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48POWDER, FOR SUSPENSION / ORAL11.25 mgExact identifier — unii candidate
22 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UITABLET, FILM COATED / ORAL98 mgExact identifier — unii candidate
17 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / SUBCUTANEOUS4.54 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, ORALLY DISINTEGRATING / ORAL187 mgExact identifier — unii candidate
39 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, ORALLY DISINTEGRATING / ORAL180 mgExact identifier — unii candidate
19 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36APOWDER, FOR SOLUTION / ORAL3767 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATROCHE / ORAL14594 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30INHALANT / ORAL0.08 mgExact identifier — unii candidate
39 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / ORAL869 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30POWDER, FOR SUSPENSION / ORAL120 mgExact identifier — unii candidate
39 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION / OPHTHALMIC4.7 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SOLUTION / SUBMUCOSAL2.94 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION / SUBCUTANEOUS675 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AGRANULE, FOR SUSPENSION / ORAL6000 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS35 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36APOWDER, FOR SUSPENSION / ORAL7093 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SUSPENSION, EXTENDED RELEASE / ORAL71 mgExact identifier — unii candidate
39 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET, EXTENDED RELEASE / ORAL173 mgExact identifier — unii candidate
39 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UIPELLET / ORAL43 mgExact identifier — unii candidate
17 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AGRANULE / ORAL1328 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR300 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SUSPENSION / SUBCUTANEOUS180 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30CAPSULE / ORAL256.4 mgExact identifier — unii candidate
39 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL1568 mgExact identifier — unii candidate
65 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1SYRUP / ORAL0.63 mg/5mlExact identifier — unii candidate
19 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1GRANULE, FOR SUSPENSION / ORAL420 mgExact identifier — unii candidate
19 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASPRAY / NASAL41.5 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACONCENTRATE / INTRAVENOUS220 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS181 mgExact identifier — unii candidate
65 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UILOZENGE / ORAL125 mgExact identifier — unii candidate
17 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, FILM COATED / ORAL330 mgExact identifier — unii candidate
22 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR113 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36APOWDER / ORAL4352 mgExact identifier — unii candidate
65 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, FILM COATED / ORAL20 mgExact identifier — unii candidate
19 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACAPSULE, COATED PELLETS / ORAL14 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SOLUTION / SUBCUTANEOUS99 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30LOZENGE / TRANSMUCOSAL100 mgExact identifier — unii candidate
39 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1POWDER, FOR SOLUTION / ORAL233 mgExact identifier — unii candidate
19 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1POWDER / ORAL63 mgExact identifier — unii candidate
19 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1GRANULE, EFFERVESCENT / ORAL30 mgExact identifier — unii candidate
19 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ATABLET, EXTENDED RELEASE / ORAL1086 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30TABLET / SUBLINGUAL17.5 mgExact identifier — unii candidate
39 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACAPSULE / ORAL1562 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30SYSTEM / INTRAVITREAL0.02 mgExact identifier — unii candidate
39 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE, COATED PELLETS / ORAL198 mgExact identifier — unii candidate
22 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET, COATED / ORAL224 mgExact identifier — unii candidate
22 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48CAPSULE, DELAYED RELEASE / ORAL72 mgExact identifier — unii candidate
22 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET, CHEWABLE / ORAL195 mgExact identifier — unii candidate
19 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASOLUTION/ DROPS / OPHTHALMIC4.6 %w/vExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR105 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ACAPSULE, DELAYED RELEASE / ORAL2043 mgExact identifier — unii candidate
65 equally ranked IID candidates
MAGNESIUM STEARATEMAGNESIUM STEARATE70097M6I30LOZENGE / ORAL420 mgExact identifier — unii candidate
39 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASUSPENSION, EXTENDED RELEASE / ORAL2464.6 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36ASUSPENSION / OPHTHALMIC9 mgExact identifier — unii candidate
65 equally ranked IID candidates
MANNITOLMANNITOL3OWL53L36AWAFER / ORAL642 mgExact identifier — unii candidate
65 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UITABLET, EXTENDED RELEASE / ORAL42 mgExact identifier — unii candidate
17 equally ranked IID candidates
CROSCARMELLOSE SODIUMCROSCARMELLOSE SODIUMM28OL1HH48TABLET / ORAL736 mgExact identifier — unii candidate
22 equally ranked IID candidates
ASPARTAMEASPARTAMEZ0H242BBR1TABLET / SUBLINGUAL8 mgExact identifier — unii candidate
19 equally ranked IID candidates
SODIUM STEARYL FUMARATESODIUM STEARYL FUMARATE7CV7WJK4UITABLET, ORALLY DISINTEGRATING / ORAL153 mgExact identifier — unii candidate
17 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077153-001LORATADINE REDIDOSELORATADINE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-1184e616aacf4f…
2026-08-18 06:07:402026-07A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-118072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-115c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-115d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-114b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-1174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-1187673890dc5c…
2021-03-12 10:30 UTC2021-03A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-115aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-118869cabd3fbd…
2020-11-12 02:37 UTC2020-11A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11c0c555d07b60…
2019-12-14 00:12 UTC2019-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-113f01610625f2…
2019-09-15 20:21 UTC2019-09A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11b00525d2431f…
2019-07-19 19:46 UTC2019-07A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-116a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-111c564ffb4f44…
2023-12-20 04:57 UTC2023-12A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-119b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-113f0d92c62455…
2023-05-13 08:27 UTC2023-05A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11053a50430f4f…
2023-01-26 05:58 UTC2023-01A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-113bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-113a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A077153-001LORATADINE REDIDOSE10MGTABLET, ORALLY DISINTEGRATING / ORAL2007-04-11f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
710cd931-0ca1-45b3-a430-14237c2365f4e2fe073f-14da-424f-a34c-486d666fd6492012-10-05WarningsExact identifier
spl id: 710cd931-0ca1-45b3-a430-14237c2365f4
spl set id: e2fe073f-14da-424f-a34c-486d666fd649

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.